Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine. 1996

A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
Children's Hospital, Hanover Medical School, Germany.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D010045 Outpatients Persons who receive ambulatory care at an outpatient department or clinic without room and board being provided. Out-patients,Out patients,Out-patient,Outpatient
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
December 2003, Transplantation proceedings,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
April 2010, Transplantation proceedings,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
March 1994, Journal of pharmaceutical sciences,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
August 1998, Transplantation proceedings,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
February 1996, Transplantation,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
August 1998, Transplantation proceedings,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
January 1994, Pharmacotherapy,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
January 1986, Developments in toxicology and environmental science,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
August 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
A Bökenkamp, and G Offner, and P F Hoyer, and K Wonigeit, and J Brodehl
June 1997, Transplantation,
Copied contents to your clipboard!